MyBlueDotsMeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR MyBlueDots2 weeks ago01 mins ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)– #AMR–These new members bring decades of experience in medicine, industry, and healthcare policy, strengthening MeMed’s work in host-response technologies. Post navigation Previous: Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025Next: Syringe exchange fears hobble fight against West Virginia HIV outbreak
People who are autistic and transgender/gender diverse have poorer health and health care, study finds MyBlueDots18 hours ago 0
Digital therapeutics: Exploring the road to commercialization across international markets MyBlueDots23 hours ago 0